Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel-An observational cohort study in Sweden.
Marie LinderMorten AndersenPublished in: Pharmacoepidemiology and drug safety (2021)
Clopidogrel users were older with a higher prevalence of concomitant medications than ticagrelor users. Our study showed increased incidences of dyspnea and respiratory bleeding (mainly epistaxis) among current ticagrelor users compared with clopidogrel users, and increased risks of gout and acute renal failure after adjustment.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- coronary artery disease
- risk factors
- physical activity
- type diabetes
- liver failure
- case report
- uric acid
- palliative care
- adipose tissue
- respiratory failure
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- hepatitis b virus
- skeletal muscle
- glycemic control
- advanced cancer
- community dwelling
- insulin resistance
- aortic dissection